Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Economic Costs of Cardiovascular Diseases in Poland Estimates for 2015-2017 Years.
Mela A, Rdzanek E, Poniatowski ŁA, Jaroszyński J, Furtak-Niczyporuk M, Gałązka-Sobotka M, Olejniczak D, Niewada M, Staniszewska A. Mela A, et al. Among authors: rdzanek e. Front Pharmacol. 2020 Sep 8;11:1231. doi: 10.3389/fphar.2020.01231. eCollection 2020. Front Pharmacol. 2020. PMID: 33013357 Free PMC article.
Cost of severe hypoglycaemia in nine European countries.
Jakubczyk M, Lipka I, Pawęska J, Niewada M, Rdzanek E, Zaletel J, Ramírez de Arellano A, Doležal T, Chekorova Mitreva B, Nagy B, Petrova G, Šarić T, Yfantopoulos J, Czech M. Jakubczyk M, et al. Among authors: rdzanek e. J Med Econ. 2016 Oct;19(10):973-82. doi: 10.1080/13696998.2016.1188823. Epub 2016 Jun 3. J Med Econ. 2016. PMID: 27163169 Free article.
The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology.
Mela A, Rdzanek E, Tysarowski A, Sakowicz M, Jaroszyński J, Furtak-Niczyporuk M, Żurek G, Poniatowski ŁA, Jagielska B. Mela A, et al. Among authors: rdzanek e. Expert Rev Pharmacoecon Outcomes Res. 2023 Jan;23(1):43-54. doi: 10.1080/14737167.2023.2140139. Epub 2022 Nov 27. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 36437684
Correction: AOTMiT reimbursement recommendations compared to other HTA agencies.
Mela A, Lis D, Rdzanek E, Jaroszyński J, Furtak-Niczyporuk M, Drop B, Blicharski T, Niewada M. Mela A, et al. Among authors: rdzanek e. Eur J Health Econ. 2025 Feb;26(1):143-146. doi: 10.1007/s10198-024-01720-z. Epub 2024 Oct 26. Eur J Health Econ. 2025. PMID: 39460843 Free PMC article. No abstract available.
Time from approval to reimbursement recommendations in healthcare systems with centralized HTA processes. Focus on the Polish HTA agency.
Mela A, Tysarowski A, Rdzanek E, Blicharski T, Jaroszyński J, Furtak-Niczyporuk M, Jahnz-Różyk K, Niewada M. Mela A, et al. Among authors: rdzanek e. Expert Rev Pharmacoecon Outcomes Res. 2024 Oct 21:1-9. doi: 10.1080/14737167.2024.2416240. Online ahead of print. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 39431604 Free article.
AOTMiT reimbursement recommendations compared to other HTA agencies.
Mela A, Lis D, Rdzanek E, Jaroszyński J, Furtak-Niczyporuk M, Drop B, Blicharski T, Niewada M. Mela A, et al. Among authors: rdzanek e. Eur J Health Econ. 2024 Nov;25(8):1291-1310. doi: 10.1007/s10198-023-01655-x. Epub 2024 Jan 23. Eur J Health Econ. 2024. PMID: 38261131 Free PMC article.